Human insulin does not increase prostate cancer risk in Taiwanese

Clinical Genitourinary Cancer

Volumn 12, Issue 1, 2014, Pages e7-

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Epidemiology; Incidence; National health insurance; Taiwan; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HUMAN INSULIN; MEGLITINIDE; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; STATIN (PROTEIN); STEROID 5ALPHA REDUCTASE INHIBITOR; SULFONYLUREA; TICLOPIDINE;

ADULT; AGE; AGED; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CORRELATIONAL STUDY; DIABETIC PATIENT; DISEASE DURATION; DOSE RESPONSE; DRUG EXPOSURE; DYSLIPIDEMIA; EVALUATION STUDY; EYE DISEASE; FOLLOW UP; HUMAN; HYPERTENSION; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; TAIWAN; TREATMENT DURATION; URINARY TRACT DISEASE;

EPIDEMIOLOGY; INCIDENCE; NATIONAL HEALTH INSURANCE; TAIWAN; TYPE 2 DIABETES MELLITUS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK; TAIWAN;

EID: 84892431906     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2013.08.004     Document Type: Article

References (22)

1. S.L. Bowker, Y. Yasui, and P. Veugelers et al. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure Diabetologia 53 2010 1631 1637
2. R. Call, M. Grimsley, and L. Cadwallader et al. Insulin-carcinogen or mitogen? Preclinical and clinical evidence from prostate, breast, pancreatic, and colorectal cancer research Postgrad Med 122 2010 158 165
3. H. Nandeesha Insulin: a novel agent in the pathogenesis of prostate cancer Int Urol Nephrol 41 2009 267 272
4. G. Williams Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling Mol Cell Endocrinol 351 2012 269 278
5. R.R. Aggarwal, C.J. Ryan, and J.M. Chan Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? Urol Oncol 31 2013 522 530
6. A. Vikram, and G. Jena Diet-induced hyperinsulinemia accelerates growth of androgen-independent PC-3 cells in vitro Nutr Cancer 64 2012 121 127
7. A.A. Lubik, J.H. Gunter, and S.C. Hendy et al. Insulin increases de novo steroidogenesis in prostate cancer cells Cancer Res 71 2011 5754 5764
8. A.M. Ribeiro, S. Pereira, and S. Andrade et al. Insulin prevents leptin inhibition of RM1 prostate cancer cell growth Pathol Oncol Res 18 2012 499 507
9. H. Nandeesha, B.C. Koner, and L.N. Dorairajan et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia Clin Chim Acta 370 2006 89 93
10. J. Hammarsten, J.E. Damber, and R. Peeker et al. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer Cancer Epidemiol 34 2010 574 579
11. A. Hitron, V. Adams, and J. Talbert et al. The influence of antidiabetic medications on the development and progression of prostate cancer Cancer Epidemiol 36 2012 e243 e250
12. R. Landberg, S.O. Andersson, and J.X. Zhang et al. Rye whole grain and bran intake compared with refined wheat decreases urinary C-peptide, plasma insulin, and prostate specific antigen in men with prostate cancer J Nutr 140 2010 2180 2186
13. P. Kurtzhals, L. Schäffer, and A. Sørensen et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use Diabetes 49 2000 999 1005
14. E. Mannucci, M. Monami, and D. Balzi et al. Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients Diabetes Care 33 2010 1997 2003
15. M. Lind, M. Fahlén, and B. Eliasson et al. The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes Prim Care Diabetes 6 2012 53 59
16. C.H. Tseng Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan BMC Cancer 13 2013 7
17. C.H. Tseng Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan Diabetologia 54 2011 2009 2015
18. C.H. Tseng Diabetes and risk of prostate cancer: a study using the National Health Insurance Diabetes Care 34 2011 616 621
19. C.H. Tseng Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study BJU Int 110 2012 668 673
20. A. Clements, B. Gao, and S.H. Yeap et al. Metformin in prostate cancer: two for the price of one Ann Oncol 22 2011 2556 2560
21. X.X. He, S.M. Tu, and M.H. Lee et al. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients Ann Oncol 22 2011 2640 2645
22. B. Carstensen, D.R. Witte, and S. Friis Cancer occurrence in Danish diabetic patients: duration and insulin effects Diabetologia 55 2012 948 958